SCHEMBL14933432

SCHEMBL14933432

O=c1[nH]c2ccc(-c3ccccc3)cc2c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.62
KDM4E B2RXH2 1/20 0.60
MEN1 O00255 1/20 0.60
TNKS O95271 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
CYP1A2 P05177 1/20 0.60
GPR3 P46089 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60
KMT2A Q03164 1/20 0.60
PARP15 Q460N3 1/20 0.60
HSD17B10 Q99714 1/20 0.60
TNKS2 Q9H2K2 1/20 0.60
BRD4 O60885 5/20 0.54
PGR P06401 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
CASP7 P55210 1/20 0.49
CASP6 P55212 1/20 0.49
CASP8 Q14790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20213773 0.88 PARP1 (0.57) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL30466765 0.88 PARP1 (0.57) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL20227594 0.88 PARP1 (0.63) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL21636104 0.88 PARP1 (0.63) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL20232184 0.87 CDK4 (0.54) KDM4EMEN1ALDH1A1LMNAGPR3
SCHEMBL20227723 0.83 PARP1 (0.51) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL25835282 0.83 TNKS2 (0.45) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL20232146 0.83 AHR (0.59) PARP1KDM4EMEN1TNKSALDH1A1
SCHEMBL17154708 0.82 CDK4 (0.57) KDM4EMEN1ALDH1A1GPR3KMT2A
SCHEMBL3365890 0.82 CDK4 (0.57) KDM4EMEN1ALDH1A1GPR3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3823958-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-08-23 EP disclosed
US-11713319-B2 Compounds having valerolactam structures MERCK PATENT GMBH (DE) 2023-08-01 US disclosed
US-11713319-B2 Compounds having valerolactam structures MERCK PATENT GMBH (DE) 2023-08-01 US disclosed
EP-3548467-B1 COMPOUNDS HAVING VALEROLACTAM STRUCTURES MERCK PATENT GMBH (DE) 2023-06-21 EP disclosed
EP-3548467-B1 COMPOUNDS HAVING VALEROLACTAM STRUCTURES MERCK PATENT GMBH (DE) 2023-06-21 EP disclosed
US-20220069231-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-03-03 US disclosed
US-20200031827-A1 COMPOUNDS HAVING VALEROLACTAM STRUCTURES MERCK PATENT GMBH (DE) 2020-01-30 US disclosed
WO-2020016264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-01-23 WO disclosed
WO-2018099846-A1 COMPOUNDS HAVING VALEROLACTAM STRUCTURES MERCK PATENT GMBH (DE) 2018-06-07 WO disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713319-B2 Compounds having valerolactam structures ACE, CYP3A4, CYP2D6 PARP1 340/4885KDM4E 587/4885MEN1 2045/4885
US-20200031827-A1 COMPOUNDS HAVING VALEROLACTAM STRUCTURES ACE, CYP3A4, CYP2D6 PARP1 340/4885KDM4E 587/4885MEN1 2045/4885
US-20220069231-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, L1CAM, EFNA1 PARP1 1804/4885KDM4E 3334/4885MEN1 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.